Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.polymedicure.com | |
Market Cap | 15,893.69 Cr. | |
Enterprise Value(EV) | 15,958.46 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 24.35 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 68.01 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 65.05 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 139.42 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 11.88 | Calculated using Price: 1,656.10 |
Dividend Yield | 0.18 | Period Ending 2023-03 |
No. of Shares Subscribed | 9.60 Cr. | 95,970,592 Shares |
FaceValue | 5 | |
About Poly Medicure Ltd. | ||
Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products. |
1 Day |
|
-3.25% |
1 Week |
|
+5.69% |
1 Month |
|
+14.38% |
3 Month |
|
+17.52% |
6 Month |
|
+66.21% |
1 Year |
|
+71.35% |
2 Year |
|
+63.62% |
5 Year |
|
+590.28% |
10 Year |
|
+1852.89% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 36.03 | 22.35 | 22.04 | 23.17 | 18.19 | 23.51 | 19.42 | 14.29 | 15.42 | |
Return on Capital Employed (%) | 38.90 | 25.59 | 24.54 | 25.69 | 22.47 | 24.80 | 21.96 | 17.42 | 19.10 | |
Return on Assets (%) | 18.97 | 12.64 | 13.06 | 13.82 | 10.49 | 12.95 | 13.15 | 11.08 | 11.90 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 196 | 229 | 272 | 338 | 381 | 435 | 966 | 1,087 | 1,242 | 1,338 | |
Non Curr. Liab. | 55 | 49 | 72 | 104 | 119 | 139 | 87 | 63 | 42 | 38 | |
Curr. Liab. | 113 | 109 | 114 | 123 | 181 | 225 | 215 | 227 | 351 | 321 | |
Minority Int. | |||||||||||
Equity & Liab. | 364 | 387 | 457 | 565 | 682 | 800 | 1,267 | 1,377 | 1,635 | 1,697 | |
Non Curr. Assets | 205 | 217 | 252 | 310 | 352 | 450 | 520 | 593 | 770 | 885 | |
Curr. Assets | 160 | 171 | 205 | 255 | 329 | 350 | 748 | 783 | 865 | 812 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 364 | 387 | 457 | 565 | 682 | 800 | 1,267 | 1,377 | 1,635 | 1,697 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 390 | 412 | 455 | 520 | 611 | 687 | 786 | 923 | 1,115 | 1,250 | |
Other Income | 8 | 8 | 14 | 14 | 18 | 18 | 18 | 38 | 36 | 50 | |
Total Income | 398 | 421 | 469 | 535 | 629 | 706 | 805 | 961 | 1,151 | 1,300 | |
Total Expenditure | -304 | -325 | -362 | -398 | -480 | -521 | -570 | -708 | -848 | -924 | |
PBIDT | 94 | 96 | 107 | 136 | 150 | 185 | 235 | 253 | 304 | 376 | |
Interest | -10 | -10 | -9 | -12 | -14 | -20 | -11 | -6 | -11 | -12 | |
Depreciation | -19 | -21 | -24 | -29 | -37 | -41 | -48 | -54 | -57 | -61 | |
Taxation | -23 | -18 | -20 | -26 | -35 | -30 | -44 | -49 | -58 | -72 | |
Exceptional Items | 20 | ||||||||||
PAT | 62 | 47 | 55 | 71 | 65 | 96 | 136 | 147 | 179 | 231 | |
Minority Interest | |||||||||||
Share Associate | 1 | 1 | 3 | ||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 62 | 48 | 55 | 71 | 65 | 96 | 136 | 147 | 179 | 234 | |
Adjusted EPS | 7 | 5 | 6 | 8 | 7 | 11 | 14 | 15 | 19 | 24 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 66 | 63 | 63 | 56 | 75 | 106 | 128 | 119 | 123 | 191 | |
Cash Fr. Inv. | -58 | -59 | -31 | -56 | -88 | -101 | -107 | -436 | -85 | -179 | |
Cash Fr. Finan. | 5 | -6 | -31 | 0 | 16 | -5 | -21 | 317 | -35 | -13 | |
Net Change | 13 | -2 | 1 | 0 | 3 | 1 | 1 | 0 | 3 | -1 | |
Cash & Cash Eqvt | 14 | 12 | 13 | 1 | 4 | 4 | 5 | 5 | 8 | 7 |
Fri, 10 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Wed, 08 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Tue, 07 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
Thu, 07 Dec 2023 |
|
|
|
|
|